Partner at Maven Capital Partners · Joined 2007
View Live Interactive Profile →David Milroy is a Partner at Maven Capital Partners and leads the Edinburgh office. His Maven profile says he joined Maven's parent company, Aberdeen Asset Management, in 2007 as Fund Manager for an early-stage technology fund in its private equity division, which became Maven in 2009. He specialises in sourcing and executing growth capital and private equity investments in Scotland, plus technology and life science deals across the UK. His career began as a scientist at GSK; after his PhD he worked at Wood Mackenzie and in Deutsche Bank's healthcare banking division providing due diligence and corporate strategy advice. He holds a First Class Honours degree, a PhD in molecular biology and gene delivery from the University of Bath and an MBA with distinction from Edinburgh University. Maven's profile lists his sector focus as life sciences, healthcare, deep tech, IT and cyber, and software, his recent investments as Podfather, PowerPhotonic, Esk, Metrion, Nami Surgical, Dxcover and Approov, and his notable exits as Quorum Cyber, Optoscribe, QikServe, Blacktrace, Calnex, Crawford Scientific, Endura, Symphonic, PrismTech, Vermilion and Novatus. Maven's own case studies name him as the Partner on Quorum Cyber and BioAscent.